Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 35-40

  Hirsch, Tamara ^a   Dallaporta, Bruno ^a   Zamzami, Naoufal ^a   Susin, Santos A ^a   Ravagnan, Luigi ^a   Marzo, Isabel ^a   Brenner, Catherine ^a   Kroemer, Guido ^a,b  

^a CNRS   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BONGKREKIC ACID; DEXAMETHASONE; DNA FRAGMENT; ENZYME INHIBITOR; ETOPOSIDE; LACTACYSTIN; PHOSPHATIDYLSERINE; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOLYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; APOPTOSIS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DEXAMETHASONE; ENZYME ACTIVATION; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MITOCHONDRIA; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0031829917     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cohen, J. J. 1993. Apoptosis. Immunol. Today 14:126.
2. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456.
3. Kumar, S., and M. F. Lavin. 1996. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 3:255.
4. Henkart, P. A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195.
5. Chinnaiyan, A. M., and V. M. Dixit. 1996. The cell-death machine. Curr. Biol. 6:555.
6. Fraser, A., and G. Evan. 1996. A license to kill. Cell 85:781.
7. Zhivotovsky, B., D. H. Burgess, D. M. Vanags, and S. Orrenius. 1997. Involvement of cellular proteolytic machinery in apoptosis. Biochem. Biophys. Res. Commun. 230:481.
8. Bump, N. J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, P. Licari, J. Mankovich, L. F. Shi, A. H. Greenberg, L. K. Miller, and W. W. Wong. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885.
9. Robertson, N. M., J. Zangrilli, T. Fernandesalnemri, P. D. Friesen, G. Litwack, and E. S. Alnemri. 1997. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res. 57:43.
10. Datta, R., H. Kojima, D. Banach, N. J. Bump, R. V. Talanian, E. S. Alnemri, R. R. Weichselbaum, W. W. Wong, and D. W. Kufe. 1997. Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272:1965.
11. Fearnhead, H. O., A. J. Rivett, D. Dinsdale, and G. M. Cohen. 1995. A preexisting protease is a common effector of thymocyte apoptosis mediated by diverse stimuli. FEES Lett. 357:242.
12. Zhu, H. J., H. O. Fearnhead, and G. M. Cohen. 1995. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett. 374:303.
13. Cain, K., S. H. Inayathussain, C. Couet, and G. M. Cohen. 1996. A cleavage-site-directed inhibitor of interleukin 1 beta-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochem. J. 314:27.
14. Slee, E. A., H. J. Zhu, S. C. Chow, M. Macfarlane, D. W. Nicholson, and G. M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.fmk) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21.
15. Jacobson, M. D., M. Weil, and M. C. Raff. 1996. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133:1041.
16. Sarin, A., M. L. Wu, and P. A. Henkart. 1996. Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:2445.
17. Xiang, J., D. T. Chao, and S. J. Korsmeyer. 1996. Bax-induced cell death may not require interleukin 1beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559.
18. McCarthy, N. J., M. K. B. Whyte, C. S. Gilbert, and G. I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215.
19. Hirsch, T., P. Marchetti, S. A. Susin, B. Dallaporta, N. Zamzami, I. Marzo, M. Geuskens, and G. Kroemer. 1997. The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15:1573.
20. Dubrez, L., I. Savoy, A. Hamman, and E. Solary. 1996. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15:5504.
21. Grimm, L. M., A. L. Goldberg, G. G. Poirier, L. M. Schwartz, and B. A. Osborne. 1996. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15:3835.
22. Sadoul, R., P. A. Fernandez, A. L. Quiquerez, I. Martinou, M. Maki, M. Schroter, J. D. Becherer, M. Irmler, J. Tschopp, and J. C. Martinou. 1996. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15:3845.
23. Cui, H. L., K. Matsui, S. Omura, S. L. Schauer, R. A. Matulka, G. E. Sonnenshein, and S. T. Ju. 1997. Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 94:7515.
24. Matsui, K., S. Omura, H. L. Cui, S. L. Schauer, G. E. Sonenshein, and S. T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27:2269.
25. Jones, M. E. E., M. F. Haire, P. M. Kloetzel, D. L. Mykles, and L. M. Schwartz. 1995. Changes in the structure and function of the multicatalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta. Dev. Biol. 169:436.
26. Low, P., K. Bussell, S. P. Daxson, M. A. Billet, R. J. Mayer, and S. E. Reynolds. 1997. Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta. FEBS Lett. 400:345.
27. Shimizu, T., and Y. Pommier. 1996. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies. Exp. Cell Res. 226:292.
28. Shinohara, K., M. Tomioka, H. Nakano, S. Tone, H. Ito, and S. Kawashima. 1996. Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317:385.
29. Tanimoto, Y., Y. Onishi, S. Hashimoto, and H. Kizaki. 1997. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. 121:542.
30. Lopes, U. G., P. Erhardt, R. J. Yao, and G. M. Cooper. 1997. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272:12893.
31. Drexler, H. C. A. 1997. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94:855.
32. Kroemer, G., N. Zamzami, and S. A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today 18:44.
33. vander Heiden, M. G., N. S. Chandal, E. K. Williamson, P. T. Shcumacker, and C. B. Thompson, 1997. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627.
34. Liu, X., C. N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147.
35. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T.-I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
36. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132.
37. Ellerby, H. M., S. J. Martin, L. M. Ellerby, S. S. Naiem, S. Rabizadeh, G. S. Salvese, C. A. Casiano, N. R. Cashman, D. R. Green, and D. E. Bredesen. 1997. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:6165.
38. Susin, S. A., N. Zamzami, M. Castedo, E. Daugas, H.-G. Wang, S. Geley, F. Fassy, J. Reed, and G. Kroemer. 1997. The central executioner of apoptosis: multiple links between protease activation and mitochondria in Fas/Apo-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 186:25.
39. Zamzami, N., P. Marchera, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S. A. Susin, P. X. Petit, B. Mignotte, and G. Kroemer. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367.
40. Marchetti, P., M. Castedo, S. A. Susin, N. Zamzami, T. Hirsch, A. Haeffner, F. Hirsch, M. Geuskens, and G. Kroemer. 1996, Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1155.
41. Kroemer, G., B. Lisardo, P. Zamzami, S. Hortelano, and C. Martinez-A. 1997. Detection of apoptosis and apoptosis associated alterations. In The Immunology Methods Manual, Ch. 14.2. R. Lefkovitz, ed. Academic Press, New York, pp. 1111-1125.
42. Reidlinger, J., A. M. Pike, P. J. Savory, R. Z. Murray, and A. J. Rivett. 1997. Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities. J. Biol. Chem. 272:24899.
43. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.-L. Vayssière, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
44. Zoratti, M., and I. Szabò. 1995. The mitochondrial permeability transition. Biochim. Biophys. Acta 1241:139.
45. Marchetti, P., T. Hirsch, N. Zamzami, M. Castedo, D. Decaudin, S. A. Susin, B. Masse, and G. Kroemer. 1996. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:4830.
46. Zamzami, N., S. A. Susin, P. Marchetti, T. Hirsch, I. Gómez-Monterrey, M. Castedo, and G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533.
47. Dong, Z., P. Saikumar, J. M. Weinberg, and M. A. Vekatachalam. 1997. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: involvement of serine but not cysteine proteases. Am. J. Pathol. 151:1205.
48. Palmer, A., A. J. Rivett, S. Thomson, K. B. Hendil, G. W. Butcher, G. Fuertes, and E. Knecht. 1996. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316:401.
49. + thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. J. Immunol. 159:4762.
50. Bernard, G., J. P. Breittmayer, M. Dematteis, P. Trampont, P. Hofman, A. Senik, and A. Bernard. 1997. Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol. 158:2543.
51. Miossec, C., V. Dutilleul, F. Fassy, and A. Diu-Hercend. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:13459.
52. Lacana, E., J. K. Ganjei, P. Vito, and L. Dadamio. 1997. Dissociation of apoptosis and activation of IL-1 beta-converting enzyme/Ced-3 proteases by ALG-2 and the truncated Alzheimer's gene ALG-3. J. Immunol. 158:5129.
53. Boise, L. H., and C. B. Thompson. 1997. Bcl-XL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94:3759.